HUM · NYSE
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | $5.83B | $4.43B | $4.03B | $4.78B | $3.06B | $1.81B | $1.44B | $1.46B |
| Selling, General & Administrative | $15.45B | $13.70B | $13.19B | $12.67B | $10.12B | $10.05B | $7.38B | $7.53B |
| Operating Income | $2.70B | $2.56B | $4.01B | $3.80B | $3.15B | $4.99B | $3.19B | $3.10B |
| Interest Expense | — | — | $493.00M | $401.00M | $326.00M | $283.00M | $242.00M | $218.00M |
| Other Income / (Expense) | -$451.00M | -$181.00M | -$137.00M | -$68.00M | $532.00M | -$103.00M | $506.00M | -$33.00M |
| Income Before Taxes | $1.44B | $1.62B | $3.33B | $3.56B | $3.42B | $4.67B | $3.47B | $2.07B |
| Provision for Income Taxes | $250.00M | $413.00M | $836.00M | $762.00M | $485.00M | $1.31B | $763.00M | $391.00M |
| Net Income | $1.19B | $1.21B | $2.49B | $2.81B | $2.93B | $3.37B | $2.71B | $1.68B |
| Basic EPS | $9.87 | $10.01 | $20.09 | $22.20 | $22.79 | $25.47 | $20.20 | $12.24 |
| Diluted EPS | $9.84 | $9.98 | $20.00 | $22.08 | $22.67 | $25.31 | $20.10 | $12.16 |
| Basic Shares Outstanding | 120.45M | 120.57M | 123.87M | 126.42M | 128.69M | 132.20M | 134.06M | 137.49M |
| Diluted Shares Outstanding | 120.83M | 120.87M | 124.44M | 127.09M | 129.40M | 133.01M | 134.73M | 138.40M |
| Period | Consensus EPS | Low | High | Estimates | Revisions |
|---|---|---|---|---|---|
| Dec 2026 | $9.08 | $9.00 | $9.41 | 9 | ↑0 ↓0 |
| Dec 2027 | $15.14 | $10.39 | $18.11 | 12 | ↑3 ↓2 |
| Dec 2028 | $26.06 | $17.85 | $36.31 | 8 | ↑3 ↓3 |
| Dec 2029 | $25.99 | $25.99 | $25.99 | 1 | ↑0 ↓0 |